nitrosonifedipine

structure in first source

Networked: 4 relevant articles (4 outcomes, 0 trials/studies)

1.	Ikeda, Yasumasa: 4 articles (01/2018 - 01/2013)
2.	Ishizawa, Keisuke: 4 articles (01/2018 - 01/2013)
3.	Izawa-Ishizawa, Yuki: 4 articles (01/2018 - 01/2013)
4.	Tamaki, Toshiaki: 4 articles (01/2018 - 01/2013)
5.	Tsuchiya, Koichiro: 4 articles (01/2018 - 01/2013)
6.	Horinouchi, Yuya: 3 articles (01/2018 - 01/2013)
7.	Imanishi, Masaki: 3 articles (01/2018 - 01/2013)
8.	Sakurada, Takumi: 3 articles (01/2018 - 01/2013)
9.	Sairyo, Eriko: 2 articles (01/2018 - 01/2017)
10.	Fujii, Shoko: 2 articles (01/2014 - 01/2013)

1.	Vascular Remodeling 01/01/2013 - "Nitrosonifedipine ameliorates angiotensin II-induced vascular remodeling via antioxidative effects."
2.	Necrosis 01/01/2017 - "Topical application of nitrosonifedipine, a novel radical scavenger, ameliorates ischemic skin flap necrosis in a mouse model."
3.	Diabetic Nephropathies (Diabetic Nephropathy) 01/01/2014 - "Nitrosonifedipine ameliorates the progression of type 2 diabetic nephropathy by exerting antioxidative effects."
4.	Cardiovascular Diseases (Cardiovascular Disease) 01/01/2018 - "We have reported that nitrosonifedipine (NO-NIF), a photodegradation product of nifedipine, has strong antioxidant and endothelial protective effects, and can suppress several cardiovascular diseases in animal models. "
5.	Aortic Aneurysm (Aneurysm, Aortic) 01/01/2018 - "Nitrosonifedipine, a Photodegradation Product of Nifedipine, Suppresses Pharmacologically Induced Aortic Aneurysm Formation."